Baty, F., Joerger, M., Früh, M., Klingbiel, D., Zappa, F., & Brutsche, M. (2017). 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling. J Transl Med.
Style de citation ChicagoBaty, Florent, Markus Joerger, Martin Früh, Dirk Klingbiel, Francesco Zappa, et Martin Brutsche. "24h-gene Variation Effect of Combined Bevacizumab/erlotinib in Advanced Non-squamous Non-small Cell Lung Cancer Using Exon Array Blood Profiling." J Transl Med 2017.
Style de citation MLABaty, Florent, et al. "24h-gene Variation Effect of Combined Bevacizumab/erlotinib in Advanced Non-squamous Non-small Cell Lung Cancer Using Exon Array Blood Profiling." J Transl Med 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.